Comunicados de prensa
Brainlab Joins World Cancer Day with Global Commitment of Access to Treatment
World Cancer Day 2015 Highlights Solutions Within Reach Across the Cancer ContinuumChicago, Illinois, February 04 — Brainlab is participating in World Cancer Day today, supporting the Union for International Cancer Control (UICC) and cancer care organizations and advocates around the world, promoting a positive and proactive approach in the fight against cancer.
The goal of this year’s World Cancer Day, under the tagline, ‘Not Beyond Us’, is to highlight that solutions do exist across the continuum of cancer care and explore how to implement strategies in the areas of healthy lifestyle choices, early detection, treatment for all and quality of life. World Cancer Day helps to shine the light on the global cancer epidemic, aiming to save millions of preventable deaths each year by raising awareness and education about the diseases and pressing governments and individuals across the world to take action.
This past year Brainlab has made great strides to demonstrate that the battle against cancer is ‘Not Beyond Us’ through innovative and agile technologies, new charitable partnerships and working closely with the American Association of Neurological Surgeons (AANS) and the American Society for Radiation Oncology (ASTRO) on a ground-breaking and substantial stereotactic radiosurgery (SRS) registry.
“Working with not-for-profits like Right.Brain Foundation e.V. to bring neuronavigation to Cambodia and Radiating Hope to bring clinical expertise to Africa fulfils the Brainlab vision to offer treatment access to all”, said Stefan Vilsmeier, President and CEO, Brainlab. “Furthermore, new technologies like Adaptive Hybrid Surgery and Automatic Brain Metastases Planning Software offer capabilities, efficiency and usability that we expect will help change the way life-threatening diseases are treated. Finally, our work in the development of the SRS registry is designed to help improve healthcare outcomes, support informed decision-making and potentially lower the cost-of-care for patients.”
According to the UICC, the global cancer epidemic is huge and is set to rise. Currently, 8.2 million people die from cancer worldwide every year, out of which, 4 million people die prematurely (aged 30 to 69 years). Furthermore, the global cancer burden is expected to continue to rise to 12 million cancer deaths per year by 2030 with global costs of cancer estimated to rise to $458 billion.
The challenges and opportunities of effective cancer care across the globe are actively researched and addressed in the R&D teams at Brainlab. Smart technologies such as Kick, Quentry, Automatic Brain Metastases Planning, Adaptive Hybrid Surgery, and Elements software modules and new partnerships, including Right.Brain Foundation e.V. and Radiating Hope support that access to and consistency of treatment can be realities for any patient, in any continent.
“At Brainlab, our commitment over the last 25 years has been unwavering; to provide advanced technology to benefit patients worldwide”, concluded Vilsmeier. “We do this by providing clinicians access to some of the latest treatment technologies, which draws upon the interconnectivity between medical devices and clinical expertise.”
Brainlab technology is in use in over 3,000 hospitals worldwide and our solutions help clinicians focus on what is most important: cancer survivorship. Brainlab is committed to being an active partner in the worldwide conversation dedicated to awareness and empowerment in a combined effort to reduce the global cancer burden by 2025.
Brainlab, headquartered in Munich, develops, manufactures and markets software-driven medical technology, enabling access to advanced, less invasive patient treatments.
Core products center on information-guided surgery, radiosurgery, precision radiation therapy, digital operating room integration, and information and knowledge exchange. Brainlab technology powers treatments in radiosurgery and radiotherapy as well as numerous surgical fields including neurosurgery, orthopedic, ENT, CMF, spine and trauma.
Privately held since its formation in 1989, Brainlab has over 5,000 systems installed in about 95 countries. Brainlab employs 1,200 people in 17 offices worldwide, including 290 research & development engineers, who form a crucial part of the product development team.
To learn more, visit brainlab.com.